{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:59:21Z","timestamp":1791939561596,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.tem.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T17:23:47Z","timestamp":1588785827000},"page":"655-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["The Immune System in Cushing\u2019s Syndrome"],"prefix":"10.1016","volume":"31","author":[{"given":"Valeria","family":"Hasenmajer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Sbardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sciarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Minnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9037-5417","authenticated-orcid":false,"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anna","family":"Venneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2020.04.004_bb0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s12020-016-1038-y","article-title":"Pituitary magnetic resonance imaging in Cushing's disease","volume":"55","author":"Vitale","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2020.04.004_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000094323","article-title":"Ectopic ACTH syndrome","volume":"35","author":"Isidori","year":"2006","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.tem.2020.04.004_bb0015","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/JC.2015-1589","article-title":"Conventional and nuclear medicine imaging in ectopic Cushing's syndrome: a systematic review","volume":"100","author":"Isidori","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0020","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1210\/jc.2003-031531","article-title":"Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis","volume":"89","author":"Storr","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0025","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1530\/EJE-09-0046","article-title":"The prevalence and characteristic features of cyclicity and variability in Cushing's disease","volume":"160","author":"Alexandraki","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0030","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2020.04.004_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314297","article-title":"Epidemiology of Cushing's syndrome","volume":"92","author":"Steffensen","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.tem.2020.04.004_bb0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0045","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-15-0308","article-title":"Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect","volume":"173","author":"Isidori","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12020-016-1146-8","article-title":"Glucocorticoid-induced osteoporosis: pathophysiological role of GH\/IGF-I and PTH\/VITAMIN D axes, treatment options and guidelines","volume":"54","author":"Mazziotti","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2020.04.004_bb0055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing's syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0065","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000443864","article-title":"Metabolic alterations and cardiovascular outcomes of cortisol excess","volume":"46","author":"Pivonello","year":"2016","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.tem.2020.04.004_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/EJE-17-0986","article-title":"Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas","volume":"178","author":"Sbardella","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-19-0464","article-title":"High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registry","volume":"181","author":"Valassi","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0085","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2020.04.004_bb0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7326\/0003-4819-101-3-334","article-title":"Opportunistic infections in endogenous Cushing's syndrome","volume":"101","author":"Graham","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0095","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1002\/cncr.26029","article-title":"Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience","volume":"117","author":"Ejaz","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.tem.2020.04.004_bb0100","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0105","first-page":"42","article-title":"Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin","volume":"85","author":"Sarlis","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/1097-0142(19920101)69:1<66::AID-CNCR2820690113>3.0.CO;2-2","article-title":"Paraneoplastic Cushing's syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer","volume":"69","author":"Dimopoulos","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.tem.2020.04.004_bb0120","article-title":"Invasive fungal infections in endogenous Cushing's syndrome","volume":"2","author":"Scheffel","year":"2010","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.tem.2020.04.004_bb0125","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.idc.2007.06.001","article-title":"Hypercortisolemia and infection","volume":"21","author":"Fareau","year":"2007","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.tem.2020.04.004_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx002","article-title":"Characteristics and mortality of pneumocystis pneumonia in patients with Cushing's syndrome: a plea for timely initiation of chemoprophylaxis","volume":"4","author":"van Halem","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.tem.2020.04.004_bb0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/23744235.2019.1682187","article-title":"High risk of activation of latent tuberculosis infection in rheumatic disease patients","volume":"52","author":"Long","year":"2020","journal-title":"Infect. Dis. (Lond.)"},{"key":"10.1016\/j.tem.2020.04.004_bb0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2265.2000.01018.x","article-title":"Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease","volume":"53","author":"Colao","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0145","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/BF03348914","article-title":"Development of autoimmune thyroid dysfunction after bilateral adrenalectomy in a patient with Carney's complex and after removal of ACTH-producing pituitary adenoma in a patient with Cushing's disease","volume":"16","author":"Takasu","year":"1993","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.tem.2020.04.004_bb0150","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJM199006143222404","article-title":"Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma","volume":"322","author":"Takasu","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0155","doi-asserted-by":"crossref","first-page":"E1670","DOI":"10.1210\/jc.2011-1317","article-title":"Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature","volume":"96","author":"da Mota","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ecl.2005.01.013","article-title":"Exogenous Cushing's syndrome and glucocorticoid withdrawal","volume":"34","author":"Hopkins","year":"2005","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.tem.2020.04.004_bb0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF03345386","article-title":"Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves","volume":"28","author":"Marino","year":"2005","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.tem.2020.04.004_bb0170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/eje.0.1450685","article-title":"Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis","volume":"145","author":"Ueland","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0175","doi-asserted-by":"crossref","first-page":"2912763","DOI":"10.1155\/2017\/2912763","article-title":"Circulatory immune cells in Cushing syndrome: bystanders or active contributors to atherometabolic injury? A study of adhesion and activation of cell surface markers","volume":"2017","author":"Aranda","year":"2017","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/cen.13521","article-title":"Translational evidence of prothrombotic and inflammatory endothelial damage in Cushing syndrome after remission","volume":"88","author":"Aranda","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0185","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11102-013-0522-0","article-title":"Elevated white blood cell counts in Cushing's disease: association with hypercortisolism","volume":"17","author":"Masri-Iraqi","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.tem.2020.04.004_bb0190","doi-asserted-by":"crossref","first-page":"112132","DOI":"10.18632\/oncotarget.22792","article-title":"The regulation of pre-metastatic niche formation by neutrophils","volume":"8","author":"Jablonska","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tem.2020.04.004_bb0195","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.CIR.98.21.2307","article-title":"Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes","volume":"98","author":"Nakagawa","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2020.04.004_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19124090","article-title":"How glucocorticoids affect the neutrophil life","volume":"19","author":"Ronchetti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2020.04.004_bb0205","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V93.8.2730","article-title":"The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocyte","volume":"93","author":"Nakagawa","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.tem.2020.04.004_bb0210","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1096\/fj.201601315R","article-title":"Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression","volume":"31","author":"Ricci","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2020.04.004_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174177","article-title":"Annexin A1 in blood mononuclear cells from patients with coronary artery disease: its association with inflammatory status and glucocorticoid sensitivity","volume":"12","author":"Bergstrom","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2020.04.004_bb0220","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1476-5381.2009.00483.x","article-title":"Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics","volume":"158","author":"Perretti","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tem.2020.04.004_bb0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40635-015-0059-9","article-title":"Impairment of neutrophilic glucocorticoid receptor function in patients treated with steroids for septic shock","volume":"3","author":"Bergquist","year":"2015","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.tem.2020.04.004_bb0230","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12020-016-1027-1","article-title":"Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors","volume":"56","author":"Tripodi","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2020.04.004_bb0235","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3389\/fimmu.2018.01440","article-title":"Neuroendocrine control of macrophage development and function","volume":"9","author":"Jurberg","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2020.04.004_bb0240","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11102-014-0567-8","article-title":"Long-term remission and recurrence rate in a cohort of Cushing's disease: the need for long-term follow-up","volume":"18","author":"Aranda","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.tem.2020.04.004_bb0245","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.10526","article-title":"Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis","volume":"46","author":"Getting","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tem.2020.04.004_bb0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/sji.12555","article-title":"Melanocortin 2, 3 and 4 receptor gene expressions are downregulated in CD8(+) T cytotoxic lymphocytes and CD19(+) B lymphocytes in rheumatoid arthritis responding to TNF-alpha inhibition","volume":"86","author":"Andersen","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.tem.2020.04.004_bb0255","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.pupt.2008.09.004","article-title":"A role for MC3R in modulating lung inflammation","volume":"21","author":"Getting","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.tem.2020.04.004_bb0260","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1096\/fj.08-113886","article-title":"Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion","volume":"22","author":"Leoni","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2020.04.004_bb0265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0303-7207(02)00410-0","article-title":"ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway","volume":"200","author":"Norman","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0270","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/oby.21887","article-title":"Increased adipocyte size, macrophage infiltration, and adverse local adipokine profile in perirenal fat in Cushing's syndrome","volume":"25","author":"Roerink","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.tem.2020.04.004_bb0275","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2018-02552","article-title":"Active Cushing disease is characterized by increased adipose tissue macrophage presence","volume":"104","author":"Lee","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0280","first-page":"1834","article-title":"Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease","volume":"87","author":"Isidori","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0285","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cellimm.2014.05.013","article-title":"Glucocorticoids regulate natural killer cell function epigenetically","volume":"290","author":"Eddy","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.tem.2020.04.004_bb0290","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbi.2017.09.004","article-title":"Chromatin organization as an indicator of glucocorticoid induced natural killer cell dysfunction","volume":"67","author":"Misale","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tem.2020.04.004_bb0295","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fimmu.2017.00432","article-title":"Distinct effects of dexamethasone on human natural killer cell responses dependent on cytokines","volume":"8","author":"Morgan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2020.04.004_bb0300","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41590-018-0185-0","article-title":"Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells","volume":"19","author":"Quatrini","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tem.2020.04.004_bb0305","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0306-4530(96)00021-2","article-title":"Immune regulation in Cushing's syndrome: relationship to hypothalamic-pituitary-adrenal axis hormones","volume":"21","author":"Kronfol","year":"1996","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.tem.2020.04.004_bb0310","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1530\/eje.0.1400299","article-title":"Natural killer cell activity in the peripheral blood of patients with Cushing's syndrome","volume":"140","author":"Masera","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0315","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0320","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1210\/jc.2018-00346","article-title":"Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study","volume":"103","author":"Venneri","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0325","unstructured":"Minnetti, M. et al. Fixing the broken clock in adrenal disorders. Focus on glucocorticoids and chronotherapy. J. Endocrinol. (in press)"},{"key":"10.1016\/j.tem.2020.04.004_bb0330","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00198-013-2588-y","article-title":"Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?","volume":"25","author":"Scillitani","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2020.04.004_bb0335","doi-asserted-by":"crossref","first-page":"180275","DOI":"10.1038\/sdata.2018.275","article-title":"Transcript- and protein-level analyses of the response of human eosinophils to glucocorticoids","volume":"5","author":"Gadkari","year":"2018","journal-title":"Sci. Data"},{"key":"10.1016\/j.tem.2020.04.004_bb0340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2019.06.019","article-title":"Metabolic syndrome is an inflammatory disorder: a conspiracy between adipose tissue and phagocytes","volume":"496","author":"Reddy","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tem.2020.04.004_bb0345","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.1201475","article-title":"Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis","volume":"332","author":"Wu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tem.2020.04.004_bb0350","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3803\/EnM.2017.32.3.353","article-title":"The eosinophil count tends to be negatively associated with levels of serum glucose in patients with adrenal Cushing syndrome","volume":"32","author":"Lee","year":"2017","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"10.1016\/j.tem.2020.04.004_bb0355","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mce.2013.05.014","article-title":"Molecular mechanisms of glucocorticoid action in mast cells","volume":"380","author":"Oppong","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0360","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3389\/fimmu.2018.01232","article-title":"Glucocorticoid-induced leucine zipper: fine-tuning of dendritic cells function","volume":"9","author":"Vetillard","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2020.04.004_bb0365","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0370","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000330416","article-title":"Adipokines and cardiovascular risk in Cushing's syndrome","volume":"95","author":"Valassi","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.tem.2020.04.004_bb0375","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2016-3931","article-title":"Interleukin-1 antagonism decreases cortisol levels in obese individuals","volume":"102","author":"Urwyler","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.004_bb0380","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism","volume":"43","author":"Geer","year":"2014","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.tem.2020.04.004_bb0385","doi-asserted-by":"crossref","first-page":"110486","DOI":"10.1016\/j.nut.2019.04.001","article-title":"Osteoporosis and osteoarthritis are two sides of the same coin paid for obesity","volume":"70","author":"Oliveira","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.tem.2020.04.004_bb0390","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2020.04.004_bb0395","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2044-5040-2-2","article-title":"TNF-alpha- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism","volume":"2","author":"De Larichaudy","year":"2012","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.tem.2020.04.004_bb0400","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejcb.2011.09.011","article-title":"Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target","volume":"91","author":"Crescioli","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.tem.2020.04.004_bb0405","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrendo.2015.168","article-title":"Hormonal control of T-cell development in health and disease","volume":"12","author":"Savino","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.004_bb0410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-5728(00)00298-8","article-title":"Molecular mechanisms and Th1\/Th2 pathways in corticosteroid regulation of cytokine production","volume":"109","author":"Kovalovsky","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.tem.2020.04.004_bb0415","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/all.12840","article-title":"BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis","volume":"71","author":"Banuelos","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.tem.2020.04.004_bb0420","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/eji.200324506","article-title":"Differential response of murine CD4+CD25+ and CD4+CD25\u2212 T cells to dexamethasone-induced cell death","volume":"34","author":"Chen","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tem.2020.04.004_bb0425","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/ard.2005.049924","article-title":"Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids","volume":"65","author":"Suarez","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.tem.2020.04.004_bb0430","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clim.2013.09.008","article-title":"Regulatory and effector T-cells are differentially modulated by dexamethasone","volume":"149","author":"Pandolfi","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tem.2020.04.004_bb0435","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.molmed.2016.07.003","article-title":"Empowering regulatory T cells in autoimmunity","volume":"22","author":"Kasper","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0440","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ejh.12978","article-title":"Effects of rituximab and dexamethasone on regulatory and proinflammatory B-cell subsets in patients with primary immune thrombocytopenia","volume":"100","author":"Gudbrandsdottir","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.tem.2020.04.004_bb0445","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1172\/JCI111757","article-title":"Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation","volume":"75","author":"Cupps","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2020.04.004_bb0450","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1073\/pnas.18.7.500","article-title":"Further concerning a parasympathetic center in the interbrain: VII. The effect of intraventricularly-injected histamine","volume":"18","author":"Cushing","year":"1932","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2020.04.004_bb0455","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00134-016-4600-4","article-title":"The new sepsis consensus definitions (Sepsis-3): the good, the not-so-bad, and the actually-quite-pretty","volume":"42","author":"Singer","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002685","article-title":"Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study","volume":"15","author":"Warny","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7110400","article-title":"Shared features of endothelial dysfunction between sepsis and its preceding risk factors (aging and chronic disease)","volume":"7","author":"Bermejo-Martin","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0470","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/CCM.0b013e318274647d","article-title":"Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome","volume":"41","author":"Drifte","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0475","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","article-title":"Current gaps in sepsis immunology: new opportunities for translational research","volume":"19","author":"Rubio","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tem.2020.04.004_bb0480","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13054-017-1767-1","article-title":"Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohort","volume":"21","author":"Chaudhary","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.tem.2020.04.004_bb0485","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMc1803563","article-title":"Long-term outcomes of the ADRENAL trial","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0490","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0495","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","article-title":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis","volume":"179","author":"Fang","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.tem.2020.04.004_bb0500","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/ALN.0000000000002955","article-title":"Hydrocortisone compared with placebo in patients with septic shock satisfying the sepsis-3 diagnostic criteria and APROCCHSS study inclusion criteria: a post hoc analysis of the ADRENAL trial","volume":"131","author":"Venkatesh","year":"2019","journal-title":"Anesthesiology"}],"container-title":["Trends in Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276020300813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276020300813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:40:01Z","timestamp":1760906401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276020300813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":100,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1043276020300813"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2020.04.004","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Immune System in Cushing\u2019s Syndrome","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}